We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
-30.94%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$86.2M
AUM Growth
-$47.2M
Cap. Flow
-$950K
Cap. Flow %
-1.1%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
VVUS
Vivus Inc
VVUS
+$950K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALKS icon
1
Alkermes
ALKS
$8.82B
$44.5M 51.62%
1,030,639
EXEL icon
2
Exelixis
EXEL
$13.9B
$31.5M 36.51%
19,070,213
VVUS
3
DELISTED
Vivus Inc
VVUS
$10.2M 11.87%
296,562
-21,300
-7% -$950K

Similar funds

Meditor Group's Q3 2014 Portfolio in Review

As of Q3 2014, Meditor Group held 3 positions worth $86.2M, down 35% from $133M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2014: portfolio turnover was 0%. Meditor Group opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Meditor Group's biggest Q3 2014 reduction was Vivus Inc, cutting an estimated $950K.
  • Meditor Group's ten largest holdings make up 100% of its $86.2M portfolio in Q3 2014.
  • Meditor Group opened 0 new positions and closed 0 in Q3 2014.
  • Meditor Group's portfolio value fell 35% quarter-over-quarter to $86.2M.

Based on Meditor Group's 13F filing for Q3 2014, filed 22 Oct 2014.